Top Markets
Coin of the day
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Classement en actions #33640
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Prix de l'action
$0.03702159
Dernière synchronisation: 2024-01-29
Capitalisation boursière
$7.21M
Changement (1 jour)
-3.08%
Changement (1 an)
0.00%
Pays
AU
Échange Antisense Therapeutics Limited (ANP)

Catégorie

Le prix ANP avec la capitalisation boursière de B
Antisense Therapeutics Limited Antisense Therapeutics Limited
ANP
$0.03702159
Capitalisation boursière de Antisense Therapeutics Limited(ANP)
Capitalisation boursière: $7.21M
En August 2026, Antisense Therapeutics Limited a une capitalisation boursière de $7.21M. Cela fait de Antisense Therapeutics Limited la 33640th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Antisense Therapeutics Limited du 2001 au 2026
ANP par rapport au top 5 des plus populaires stocks
Prix pour ANP L’actif B La capitalisation boursière de B Résultats
Antisense Therapeutics Limited Antisense Therapeutics Limited
$28,010.37 $7.21M
$5.452T +75,659,452.31%
Antisense Therapeutics Limited Antisense Therapeutics Limited
$23,068.63 $7.21M
$4.490T +62,311,190.82%
Antisense Therapeutics Limited Antisense Therapeutics Limited
$21,385.43 $7.21M
$4.162T +57,764,663.74%
Antisense Therapeutics Limited Antisense Therapeutics Limited
$18,888.15 $7.21M
$3.676T +51,019,190.40%
Antisense Therapeutics Limited Antisense Therapeutics Limited
$14,555.48 $7.21M
$2.833T +39,316,102.67%